» Articles » PMID: 31680165

The DisGeNET Knowledge Platform for Disease Genomics: 2019 Update

Overview
Specialty Biochemistry
Date 2019 Nov 5
PMID 31680165
Citations 1136
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D.

Citing Articles

Changes in the Proteomic Profile After Audiogenic Kindling in the Inferior Colliculus of the GASH/Sal Model of Epilepsy.

Zeballos L, Garcia-Peral C, Ledesma M, Auzmendi J, Lazarowski A, Lopez D Int J Mol Sci. 2025; 26(5).

PMID: 40076950 PMC: 11900993. DOI: 10.3390/ijms26052331.


Discovery of Herbal Remedies and Key Components for Major Depressive Disorder Through Biased Random Walk Analysis on a Multiscale Network.

Lee J, Choi S, Lee D, Kang H, Lee J, Kim J Int J Mol Sci. 2025; 26(5).

PMID: 40076790 PMC: 11900307. DOI: 10.3390/ijms26052162.


Therapeutic Mechanisms of Medicine Food Homology Plants in Alzheimer's Disease: Insights from Network Pharmacology, Machine Learning, and Molecular Docking.

Wen S, Han Y, Li Y, Zhan D Int J Mol Sci. 2025; 26(5).

PMID: 40076742 PMC: 11899993. DOI: 10.3390/ijms26052121.


Augmenting the human interactome for disease prediction through gene networks inferred from human cell atlas.

Sung E, Cha J, Baek S, Lee I Anim Cells Syst (Seoul). 2025; 29(1):11-20.

PMID: 40066175 PMC: 11892045. DOI: 10.1080/19768354.2025.2472002.


Computational pharmacology-based molecular mechanism investigation of cinnamaldehyde intervention in nephrotic syndrome.

Zeng Y, Li Q, Xie Z, Zhu J, Chen S, Sun J Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40064660 DOI: 10.1007/s00210-025-03925-2.


References
1.
Xue A, Wu Y, Zhu Z, Zhang F, Kemper K, Zheng Z . Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018; 9(1):2941. PMC: 6063971. DOI: 10.1038/s41467-018-04951-w. View

2.
McLaren W, Gil L, Hunt S, Riat H, Ritchie G, Thormann A . The Ensembl Variant Effect Predictor. Genome Biol. 2016; 17(1):122. PMC: 4893825. DOI: 10.1186/s13059-016-0974-4. View

3.
Schriml L, Mitraka E, Munro J, Tauber B, Schor M, Nickle L . Human Disease Ontology 2018 update: classification, content and workflow expansion. Nucleic Acids Res. 2018; 47(D1):D955-D962. PMC: 6323977. DOI: 10.1093/nar/gky1032. View

4.
Rehm H, Berg J, Brooks L, Bustamante C, Evans J, Landrum M . ClinGen--the Clinical Genome Resource. N Engl J Med. 2015; 372(23):2235-42. PMC: 4474187. DOI: 10.1056/NEJMsr1406261. View

5.
Bodenreider O . The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2003; 32(Database issue):D267-70. PMC: 308795. DOI: 10.1093/nar/gkh061. View